The euroPLX partnering platform is a year-round, continuous business development instrument for the pharmaceutical industry since 1995 which culminates in three partnering conferences per year, where high-level business development executives from all over the world convene for two days to discuss and negotiate pharma deals in a highly organised process.
The partnering scope is from patented and generic (incl. bio-generics and biosimilars), prescription and OTC drugs to nutraceuticals - development, licensing, marketing, promotion, and distribution.
In addition, attending companies are expected to offer or look for R&D services, regulatory services, supporting technologies (e.g. new drug delivery, medical devices), contract manufacture, and, to some extent, the supply of APIs and intermediates.